Carcinoma, Non-Small-Cell Lung
"Carcinoma, Non-Small-Cell Lung" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
Descriptor ID |
D002289
|
MeSH Number(s) |
C04.588.894.797.520.109.220.249 C08.381.540.140.500 C08.785.520.100.220.500
|
Concept/Terms |
Carcinoma, Non-Small-Cell Lung- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Non Small Cell Lung
- Carcinomas, Non-Small-Cell Lung
- Lung Carcinoma, Non-Small-Cell
- Lung Carcinomas, Non-Small-Cell
- Non-Small-Cell Lung Carcinomas
- Nonsmall Cell Lung Cancer
- Non-Small-Cell Lung Carcinoma
- Non Small Cell Lung Carcinoma
- Carcinoma, Non-Small Cell Lung
- Non-Small Cell Lung Cancer
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Non-Small-Cell Lung".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Non-Small-Cell Lung".
This graph shows the total number of publications written about "Carcinoma, Non-Small-Cell Lung" by people in this website by year, and whether "Carcinoma, Non-Small-Cell Lung" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 11 | 2 | 13 |
1995 | 13 | 1 | 14 |
1996 | 10 | 5 | 15 |
1997 | 13 | 6 | 19 |
1998 | 13 | 3 | 16 |
1999 | 17 | 6 | 23 |
2000 | 22 | 5 | 27 |
2001 | 18 | 4 | 22 |
2002 | 20 | 5 | 25 |
2003 | 41 | 7 | 48 |
2004 | 53 | 5 | 58 |
2005 | 51 | 8 | 59 |
2006 | 53 | 11 | 64 |
2007 | 60 | 8 | 68 |
2008 | 72 | 8 | 80 |
2009 | 69 | 5 | 74 |
2010 | 69 | 11 | 80 |
2011 | 84 | 7 | 91 |
2012 | 80 | 13 | 93 |
2013 | 96 | 8 | 104 |
2014 | 87 | 5 | 92 |
2015 | 85 | 10 | 95 |
2016 | 74 | 7 | 81 |
2017 | 78 | 8 | 86 |
2018 | 90 | 11 | 101 |
2019 | 85 | 8 | 93 |
2020 | 113 | 8 | 121 |
2021 | 105 | 6 | 111 |
2022 | 101 | 2 | 103 |
2023 | 107 | 1 | 108 |
2024 | 21 | 0 | 21 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Non-Small-Cell Lung" by people in Profiles.
-
An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy. J Nucl Med. 2024 Apr 01; 65(4):520-526.
-
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC. J Exp Clin Cancer Res. 2024 Mar 15; 43(1):81.
-
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer Res Commun. 2024 Mar 14; 4(3):786-795.
-
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan. Cancer Treat Rev. 2024 Apr; 125:102720.
-
Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer. Cancer Lett. 2024 Apr 28; 588:216780.
-
Development and Revision of Meaningful Stage Descriptors for M1a Non-Small Cell Lung Cancer. Chest. 2024 Mar; 165(3):490-491.
-
2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation. Radiographics. 2024 Mar; 44(3):e230136.
-
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations. Lung Cancer. 2024 Apr; 190:107512.
-
A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer. Clin Cancer Res. 2024 02 16; 30(4):655-662.
-
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types. Clin Cancer Res. 2024 02 16; 30(4):836-848.